SURVEY ON POST VACCINATION REACTIONS IN INDIANS AFTER COVAXIN AND COVISHIELD VACCINATION Authors: Satyalakshmi S , RAMYA N, SUSHMA K, AKSHAY A, GUNA U AND RAMARAO B
ABSTRACT
India has started vaccination against Covid-19 on 16th January 2021. Till now, approximately 88
lakhs people between 18-44 years, 90 lakhs of Indians between 45-60 years, and 67 lakhs of
Indians above 60 years were vaccinated with the currently approved vaccines. All vaccines
available in India can produce some common adverse reactions. A Survey was conducted by
asking a questioner through a phone call to vaccinated individuals. A total of 3127 people above
45 years, who were vaccinated with covaxin and covishield from 02.03.2021 to 29.03.2021 have
participated in this survey. Fever, headache, fatigue, myalgia, flu-like symptoms, pain at the site
of injection, and joint pains were the common post-vaccination reactions were observed in more
than 50% of vaccinated people. Only 4 deaths were happened out of 3127 people. Paired t-test
was applied to evaluate the post-vaccine adverse reactions. Null hypothesis (H0) was accepted
(P>0.05), people vaccinated with two brands of vaccines equally suffered from feverish
symptoms. Null hypothesis (H0) was rejected (P<0.05), there is a significant difference in the
vaccinated people suffering from body pains. Severe body pains were observed in Covishield vaccinated people. There is no gender difference observed in this study both the genders equally
reported the adverse reactions. This survey can improve the confidence in government-approved
vaccines. This study helps to educate the public, dispelling misinformation, and reduce hesitancy
on the vaccine.
Keywords: Survey, Covaxin, Covishield, Post-vaccination, adverse reactions, Myalgia
Publication date: 01/07/2022 https://ijbpas.com/pdf/2022/July/MS_IJBPAS_2022_6227.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.7.6227